Regina E. Groves - 03 Jan 2023 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role
Director
Signature
/s/ Paul Kim as Attorney-in-Fact
Issuer symbol
FLGT
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
04 Jan 2023, 15:39:38 UTC
Previous filing
27 May 2022
Next filing
22 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLGT Common Stock Award $0 +4,000 $0.000000 4,000 03 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLGT Stock Option (Right to Buy) Award $0 +10,000 $0.000000 10,000 03 Jan 2023 Common Stock 10,000 $30.66 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after January 3, 2023, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date.
F2 The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after January 3, 2023, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date.